In Reply: Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis

Affiliations

¹ Hospices Civils de Lyon, Institut de Parasitologie Mycologie Médicale, Hôpital de la Croix-Rousse, Lyon, France, Integrative Physiology of the Brain Arousal Systems, Centre de Recherche en Neurosciences de Lyon, INSERM U1028-CNRS UMR 5292, Faculté de Médecine, Université Claude Bernard Lyon 1, Lyon, France Hospices Civils de Lyon, Institut de Parasitologie Mycologie Médicale, Hôpital de la Croix-Rousse, Lyon, France.

Comment

Damien Dupont et al. Pediatr Infect Dis J. 2017 Mar.

. 2017 Mar;36(3):350.

doi: 10.1097/INF.0000000000001436.

¹ Hospices Civils de Lyon, Institut de Parasitologie Mycologie Médicale, Hôpital de la Croix-Rousse, Lyon, France, Integrative Physiology of the Brain Arousal Systems, Centre de Recherche en Neurosciences de Lyon, INSERM U1028-CNRS UMR 5292, Faculté de Médecine, Université Claude Bernard Lyon 1, Lyon, France Hospices Civils de Lyon, Institut de Parasitologie Mycologie Médicale, Hôpital de la Croix-Rousse, Lyon, France.

No abstract available

Comment on

Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
Teil J, Dupont D, Charpiat B, Corvaisier S, Vial T, Leboucher G, Wallon M, Peyron F. Teil J, et al. Pediatr Infect Dis J. 2016 Jun;35(6):634-8. doi: 10.1097/INF.0000000000001120. Pediatr Infect Dis J. 2016. PMID: 26906163
Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
Chemla C, Villena I. Chemla C, et al. Pediatr Infect Dis J. 2017 Mar;36(3):349-350. doi: 10.1097/INF.0000000000001435. Pediatr Infect Dis J. 2017. PMID: 28187118 No abstract available.